153 related articles for article (PubMed ID: 1562527)
1. 3-Alkyl-2-phenylbenzo[b]thiophenes: nonsteroidal estrogen antagonists with mammary tumor inhibiting activity.
von Angerer E; Erber S
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):557-62. PubMed ID: 1562527
[TBL] [Abstract][Full Text] [Related]
2. 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity.
Polossek T; Ambros R; von Angerer S; Brandl G; Mannschreck A; von Angerer E
J Med Chem; 1992 Sep; 35(19):3537-47. PubMed ID: 1404234
[TBL] [Abstract][Full Text] [Related]
3. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
Erber S; Ringshandl R; von Angerer E
Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
[TBL] [Abstract][Full Text] [Related]
4. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
von Angerer E; Birnböck H; Knebel N
Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
[TBL] [Abstract][Full Text] [Related]
5. 2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activity.
von Angerer E; Strohmeier J
J Med Chem; 1987 Jan; 30(1):131-6. PubMed ID: 3806590
[TBL] [Abstract][Full Text] [Related]
6. Benzo[a]carbazole derivatives. Synthesis, estrogen receptor binding affinities, and mammary tumor inhibiting activity.
von Angerer E; Prekajac J
J Med Chem; 1986 Mar; 29(3):380-6. PubMed ID: 3950918
[TBL] [Abstract][Full Text] [Related]
7. 2-Phenylindoles with sulfur containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.
Biberger C; von Angerer E
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):31-43. PubMed ID: 8809184
[TBL] [Abstract][Full Text] [Related]
8. 2-Phenylbenzo[b]thiophene-based antiestrogens with mammary tumor inhibiting activity.
Leichtl S; von Angerer E
Arch Pharm (Weinheim); 1998 Sep; 331(9):283-9. PubMed ID: 9793483
[TBL] [Abstract][Full Text] [Related]
9. 2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.
Schneider MR
J Med Chem; 1986 Aug; 29(8):1494-8. PubMed ID: 3735317
[TBL] [Abstract][Full Text] [Related]
10. 2-Phenylindole-linked [2-(aminoalkyl)pyridine]dichloroplatinum(II): complexes with a selective action on estrogen receptor positive mammary tumors.
Knebel NG; von Angerer E
J Med Chem; 1991 Jul; 34(7):2145-52. PubMed ID: 2066987
[TBL] [Abstract][Full Text] [Related]
11. Influence of alkyl-chain fluorination on the action of mammary tumor inhibiting 2,3-bis(hydroxyphenyl)butanes and 2,3-bis(hydroxyphenyl)but-2-enes.
Hartmann RW; Heindl A; Schneider MR; Schönenberger H
J Med Chem; 1986 Mar; 29(3):322-8. PubMed ID: 3005573
[TBL] [Abstract][Full Text] [Related]
12. Dibenzo[a,f]quinolizines: syntheses and cytostatic activity in estrogen-sensitive tumor cells.
von Angerer S; Seidl E; Mannschreck A; von Angerer E; Wiegrebe W
Anticancer Drug Des; 1994 Feb; 9(1):25-40. PubMed ID: 8141964
[TBL] [Abstract][Full Text] [Related]
13. Ring-substituted 1,2-dialkylated 1,2-bis(hydroxyphenyl)ethanes. 3. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of 2,2'-disubstituted butestrols and 6,6'-disubstituted metabutestrols.
Hartmann RW; Heindl A; Schwarz W; Schönenberger H
J Med Chem; 1984 Jul; 27(7):819-24. PubMed ID: 6330356
[TBL] [Abstract][Full Text] [Related]
14. Dibenzo[a,g]quinolizin-8-ones: synthesis, estrogen receptor affinities, and cytostatic activity.
von Angerer S; Brandl G; Mannschreck A; Weimar C; Wiegrebe W
Anticancer Drug Des; 1992 Oct; 7(5):351-63. PubMed ID: 1388628
[TBL] [Abstract][Full Text] [Related]
15. Potential antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,2-dialkyl-1,2-bis(3'-hydroxyphenyl)ethanes.
Hartmann RW; Buchborn H; Kranzfelder G; Schönenberger H; Bogden A
J Med Chem; 1981 Oct; 24(10):1192-7. PubMed ID: 6276542
[TBL] [Abstract][Full Text] [Related]
16. 2-Phenylindenes: development of a new mammary tumor inhibiting antiestrogen by combination of estrogenic side effect lowering structural elements.
Schneider MR; Ball H
J Med Chem; 1986 Jan; 29(1):75-9. PubMed ID: 3941415
[TBL] [Abstract][Full Text] [Related]
17. Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes.
Hartmann RW; Schwarz W; Heindl A; Schönenberger H
J Med Chem; 1985 Sep; 28(9):1295-301. PubMed ID: 2993619
[TBL] [Abstract][Full Text] [Related]
18. 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism.
von Angerer E; Biberger C; Holler E; Koop R; Leichtl S
J Steroid Biochem Mol Biol; 1994 May; 49(1):51-62. PubMed ID: 8003439
[TBL] [Abstract][Full Text] [Related]
19. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
Wakeling AE; Valcaccia B
J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
[TBL] [Abstract][Full Text] [Related]
20. Ester derivatives of the mammary-tumor-inhibiting antiestrogen 2,3-bis(2-fluoro-4-hydroxyphenyl)-2,3-dimethylbutane.
Schwarz W; Hartmann RW; Engel J; Schneider MR; Schönenberger H
J Cancer Res Clin Oncol; 1989; 115(2):161-5. PubMed ID: 2715167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
